OPERON ELEVATEPLUS | REGULATORY DUE DILIGENCE FOR MEDICAL DEVICES
Medical Device Due Diligence & Regulatory Consulting Services in Germany
Operon Strategist delivers structured regulatory due diligence services tailored for private equity, venture capital, and corporate acquirers evaluating medical technology assets in Germany and the wider European market. Our assessments go far beyond basic checklists, providing deep visibility into EU MDR/IVDR compliance maturity, technical file readiness, and hidden regulatory liabilities. By delivering decision-grade intelligence, we help investors uncover hidden operational gaps, protect their valuations, and execute strategic deals with total confidence.
Take the Next Step in Market Expansion
Connect with our regulatory experts to de-risk your investment, streamline EU MDR/IVDR compliance, or accelerate your German market access.
Operon ElevatePlus
Regulatory Due Diligence for Medical Devices Service Portfolio
EU MDR / IVDR Pathway & Approval Status Assessment
Validation of device classification and intended use
Review of current and planned regulatory approval routes
Assessment of submission, approval, and commitment status
Identification of approval dependencies impacting deal timelines
Markets covered: US FDA, EU MDR/IVDR, UKCA, CDSCO, SFDA, and other global jurisdictions
Compliance & Technical Documentation Review
Evaluation of technical documentation and dossier completeness
ISO 13485 and Quality Management System compliance assessment
Review of labeling, IFU, claims, and promotional compliance risks
Assessment of Post-Market Surveillance and vigilance obligations
Manufacturing & Quality System (QMS) Due Diligence
Review of manufacturing licenses and site authorizations
QMS maturity assessment against certification scope
Inspection readiness analysis (FDA, Notified Body, CDSCO)
Review of audit observations, CAPAs, and open nonconformities
Identification of process validation and production control risks
Predicate, Benchmark & Regulatory Precedent Analysis
Identification of comparable approved devices
Review of substantial equivalence and regulatory precedents
Competitive regulatory positioning and approval learnings
Clinical Data & Evidence Portfolio Evaluation
Review of clinical, performance, usability, and real-world data
Alignment with FDA, EU MDR/IVDR, and global evidence expectations
Identification of evidence gaps and post-market study risks
Post-Market Surveillance & Regulatory Liability Assessment
Classification of risks as critical, major, or manageable across performance, usability, and real-world data
Identification of regulatory non-compliance exposure
Approval dependency and enforcement risk evaluation
Estimation of remediation effort, cost, and timeline
Why Investors Choose Operon Strategist for MedTech M&A
Global exposure, structured thinking, and execution-ready expertise
Global Regulatory Expertise Across US, EU, UK, India, GCC & Emerging Markets
Coverage of Medical Devices & IVDs Across All Risk Classes (Class I, IIa, IIb, III & IVDs)
Experience Supporting Investment, M&A & Strategic Transactions
Proven Insights Aligned with Real-World Approvals & Inspections
Thorough medical device due diligence is essential to de-risking investments and M&A transactions within Europe’s strict regulatory climate. We support investors and target companies with comprehensive medical device regulatory due diligence and robust quality system due diligence to evaluate absolute market readiness. Each engagement provides a detailed due diligence report covering risk reclassifications, Notified Body audit history, and GSPR compliance. Crucially, we translate technical risks into direct impacts on valuation and transaction timelines, providing clear, actionable pre-close and post-close remediation roadmaps.
Operon Regulatory Due Diligence for Medical Devices Advantage
Identify hidden regulatory liabilities, technical file gaps, and compliance exposure before you invest, acquire, or partner—delivering decision-grade intelligence for European MedTech transactions
Independent, Execution-Neutral Regulatory Assessments
Translation of Regulatory Exposure into Business & Valuation Impact
Market-Wise, Approval-Focused Risk Visibility
Practical Remediation & Post-Transaction Planning Insights
You Might Also Be Interested in
frequently asked questions
What does a typical medical device due diligence assessment cover for a target company in Germany?
An assessment evaluates the target asset’s entire compliance history. This includes verifying active CE certificates under EU MDR/IVDR, inspecting tech documentation, reviewing clinical data portfolios, analyzing open Corrective and Preventive Actions (CAPA), and evaluating post-market surveillance records to flag any hidden regulatory liabilities before closing.
Why is quality system due diligence critical during a medical technology acquisition or investment?
A thorough quality system due diligence ensures that the target company’s manufacturing controls are fundamentally compliant with EN ISO 13485 and European market rules. Spotting hidden gaps in the quality process early prevents unexpected post-transaction remediation expenses, shields against Notified Body audit failures, and protects your underlying valuation.
How has the ongoing transition to EU MDR and IVDR shifted the focus of regulatory due diligence services?
The strict implementation of EU MDR (2017/745) and IVDR (2017/746) has significantly escalated risks for investors. Legacy devices now face much tougher clinical evidence rules and potential reclassification. Due diligence services map out exactly whether a target’s current portfolio can maintain market access under the new rules or if a costly technical rewrite will be required.
What actionable insights are provided in a final medical device due diligence report?
The final report translates complex technical and regulatory exposures into direct business impacts. It offers a structured risk matrix, isolates potential deal-breaking gaps, evaluates how compliance issues affect transaction timelines, and provides clear, actionable pre-close and post-close remediation plans.
Identify Hidden Regulatory Liabilities Before You Close
Speak with our MedTech due diligence experts
Please provide the following information and we’ll put you in touch with the right person.